General

Pronunciation:

Trade Name(s)

  • KRX-0401

Ther. Class.
temporary class currently an orphan drug being fast-tracked for colon CA

Indications

Action

Therapeutic Effect(s):

Pharmacokinetics

Absorption:

Distribution:

Metabolism and Excretion:

Half-life:

TIME/ACTION PROFILE

ROUTEONSETPEAKDURATION

Contraindication/Precautions

Contraindicated in:

    Use Cautiously in:

    Adverse Reactions/Side Effects

    * CAPITALS indicate life-threatening.
    Underline indicate most frequent.

    Interactions

    Drug-Drug

    Route/Dosage

    PO: (Adults)

    Availability

    Assessment

      Potential Diagnoses

      • Activity intolerance

      Implementation

        Patient/Family Teaching

        Evaluation/Desired Outcomes

        perifosine is a sample topic from the Davis's Drug Guide.

        To view other topics, please or purchase a subscription.

        Medicine Central™ is a quick-consult mobile and web resource that includes diagnosis, treatment, medications, and follow-up information on over 700 diseases and disorders, providing fast answers—anytime, anywhere. Learn more.

        Citation

        * When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
        TY - ELEC T1 - perifosine ID - 110532 A1 - Quiring,Courtney, AU - Sanoski,Cynthia A, AU - Vallerand,April Hazard, BT - Davis's Drug Guide UR - https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/110532/all/perifosine PB - F.A. Davis Company ET - 16 DB - Medicine Central DP - Unbound Medicine ER -